Narnolia

Narnolia

GLENMARK PHARMACEUTICALS LTD.

NSE : GLENMARKBSE : 532296ISIN CODE : INE935A01035Industry : Pharmaceuticals & DrugsHouse : Glenmark
BSE512.25-8.2 (-1.58 %)
PREV CLOSE ( ) 520.45
OPEN PRICE ( ) 520.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 135041
TODAY'S LOW / HIGH ( )508.50 524.00
52 WK LOW / HIGH ( )168 572.7
NSE512.10-8.3 (-1.59 %)
PREV CLOSE( ) 520.40
OPEN PRICE ( ) 521.90
BID PRICE (QTY) 512.10 (823)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1849462
TODAY'S LOW / HIGH( ) 508.05 524.75
52 WK LOW / HIGH ( )161.65 573.05
ChairmanGlenn Saldanha
Managing DirectorGlenn Saldanha
Company SecretaryHarish Kuber
Executive DirectorCherylann Pinto
VS Mani
Non Executive DirectorRajesh V Desai
B E Saldanha
Non Executive Independent DirectorBrian W Tempest
Bernard Munos
Sridhar Gorthi
D R Mehta
Saira Ramasastry
Dipankar Bhattacharjee
Incorporation Year : 18-11 1977

Registered Office :

Address : B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, Mumbai,
Maharashtra-400026 .

Phone :

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE,MCX

Directory

current IPO
  • --
upcoming IPO
Narnolia Research & Advisory Narnolia Online | media Room